CRL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CRL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Charles River Laboratories International's Revenue for the three months ended in Jun. 2024 was $1,026 Mil. Charles River Laboratories International's average Accounts Receivable for the three months ended in Jun. 2024 was $579 Mil. Hence, Charles River Laboratories International's Receivables Turnover for the three months ended in Jun. 2024 was 1.77.
The historical data trend for Charles River Laboratories International's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Receivables Turnover | Get a 7-Day Free Trial | 6.85 | 6.61 | 7.24 | 7.58 | 7.26 |
Charles River Laboratories International Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Receivables Turnover | Get a 7-Day Free Trial | 1.80 | 1.74 | 1.73 | 1.73 | 1.77 |
For the Diagnostics & Research subindustry, Charles River Laboratories International's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Charles River Laboratories International's Receivables Turnover falls into.
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
Charles River Laboratories International's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as
Receivables Turnover (A: Dec. 2023 ) | |||||||
= | Revenue | / | Average Total Inventories | ||||
= | Revenue (A: Dec. 2023 ) | / ( | (Accounts Receivable (A: Dec. 2022 ) | + | Accounts Receivable (A: Dec. 2023 )) | / | count ) |
= | 4129.409 | / ( | (559.41 | + | 578.077) | / | 2 ) |
= | 4129.409 | / | 568.7435 | ||||
= | 7.26 |
Charles River Laboratories International's Receivables Turnover for the quarter that ended in Jun. 2024 is calculated as
Receivables Turnover (Q: Jun. 2024 ) | |||||||
= | Revenue | / | Average Total Inventories | ||||
= | Revenue (Q: Jun. 2024 ) | / ( | (Accounts Receivable (Q: Mar. 2024 ) | + | Accounts Receivable (Q: Jun. 2024 )) | / | count ) |
= | 1026.117 | / ( | (590.594 | + | 568.283) | / | 2 ) |
= | 1026.117 | / | 579.4385 | ||||
= | 1.77 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International (NYSE:CRL) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Thank you for viewing the detailed overview of Charles River Laboratories International's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Joseph W Laplume | officer: EVP, Corp Strategy & Develop | 251 BALLARDVALE STREET, WILMINGTON MA 01887 |
James C Foster | director, officer: President and CEO | 251 BALLARDVALE ST, WILMINGTON MA 01887 |
George Massaro | director | |
Michael Gunnar Knell | officer: CSVP&Chief Accounting Officer | BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821 |
Victoria L Creamer | officer: EVP & Chief People Officer | 164 PINE HILL ROAD, NEW FAIRFIELD CT 06812 |
William D Barbo | officer: Corporate Executive VP & CCO | 251 BALLARDVALE STREET, WILMINGTON MA 01887 |
Shannon M Parisotto | officer: CEVP, Disc & Safety Assessment | 251 BALLARDVALE ST, WILMINGTON MA 01887 |
Birgit Girshick | officer: Corporate Executive VP | 251 BALLARDVALE STREET, WILMINGTON MA 01887 |
Richard F Wallman | director | HONEYWELL, 101 COLUMBIA ROAD, MORRISTOWN NJ 07962 |
Flavia Pease | officer: Corporate Executive VP | 251 BALLARDVALE STREET, WILMINGTON MA 01887 |
David Ross Smith | officer: Corporate Executive VP & CFO | 251 BALLARDVALE STREET, WILMINGTON MA 01887 |
Deborah Turner Kochevar | director | 251 BALLARDVALE STREET, WILMINGTON MA 01887 |
Milne George M Jr | director | |
Stephen D Chubb | director | C/O MATRITECH INC, 330 NEVADA STREET, NEWTON MA 02460 |
George Llado | director | 251 BALLARDVALE STREET, WILMINGTON MA 01887 |
From GuruFocus
By Business Wire • 07-08-2024
By GuruFocus Research • 09-25-2024
By Marketwired • 06-12-2024
By GuruFocus Research • 07-30-2024
By Marketwired • 08-22-2024
By Business Wire • 06-17-2024
By Business Wire • 06-06-2024
By Business Wire • 07-30-2024
By GuruFocus Research • 08-12-2024
By GuruFocus Research • 08-08-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.